SMTL ID : 7jw0.1

SARS-CoV-2 spike in complex with the S304 neutralizing antibody Fab fragment

Coordinates

PDB Format Compare

Method

ELECTRON MICROSCOPY

Oligo State

hetero-3-3-3-mer

Ligands

12 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG-NAG.1: 2 residues within 4Å: Chain A: N.820, Q.823 No protein-ligand interaction detected (PLIP) NAG-NAG.2: 3 residues within 4Å: Chain A: N.1117, H.1120, F.1122 No protein-ligand interaction detected (PLIP) NAG-NAG.3: 3 residues within 4Å: Chain A: I.1151, V.1152, N.1153 No protein-ligand interaction detected (PLIP) NAG-NAG.5: 2 residues within 4Å: Chain A: C.34, N.36 No protein-ligand interaction detected (PLIP) NAG-NAG.6: 2 residues within 4Å: Chain D: N.820, Q.823 No protein-ligand interaction detected (PLIP) NAG-NAG.7: 3 residues within 4Å: Chain D: N.1117, H.1120, F.1122 No protein-ligand interaction detected (PLIP) NAG-NAG.8: 3 residues within 4Å: Chain D: I.1151, V.1152, N.1153 No protein-ligand interaction detected (PLIP) NAG-NAG.10: 2 residues within 4Å: Chain D: C.34, N.36 No protein-ligand interaction detected (PLIP) NAG-NAG.11: 2 residues within 4Å: Chain G: N.820, Q.823 No protein-ligand interaction detected (PLIP) NAG-NAG.12: 3 residues within 4Å: Chain G: N.1117, H.1120, F.1122 No protein-ligand interaction detected (PLIP) NAG-NAG.13: 3 residues within 4Å: Chain G: I.1151, V.1152, N.1153 No protein-ligand interaction detected (PLIP) NAG-NAG.15: 2 residues within 4Å: Chain G: C.34, N.36 No protein-ligand interaction detected (PLIP)

3 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose

NAG-NAG-BMA.4: 4 residues within 4Å: Chain A: G.358, F.361, N.362, V.386 No protein-ligand interaction detected (PLIP) NAG-NAG-BMA.9: 4 residues within 4Å: Chain D: G.358, F.361, N.362, V.386 No protein-ligand interaction detected (PLIP) NAG-NAG-BMA.14: 4 residues within 4Å: Chain G: G.358, F.361, N.362, V.386 No protein-ligand interaction detected (PLIP)

36 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG.16: 2 residues within 4Å: Chain A: F.78, N.80 Ligand excluded by PLIP NAG.17: 3 residues within 4Å: Chain A: N.141, A.142, T.143 Ligand excluded by PLIP NAG.18: 4 residues within 4Å: Chain A: G.218, G.251, I.252, N.253 Ligand excluded by PLIP NAG.19: 2 residues within 4Å: Chain A: N.299, N.301 Ligand excluded by PLIP NAG.20: 2 residues within 4Å: Chain A: N.350, Q.599 Ligand excluded by PLIP NAG.21: 1 residues within 4Å: Chain A: N.622 Ligand excluded by PLIP NAG.22: 1 residues within 4Å: Chain A: N.635 Ligand excluded by PLIP NAG.23: 3 residues within 4Å: Chain A: H.674, V.675, N.676 Ligand excluded by PLIP NAG.24: 2 residues within 4Å: Chain A: N.728, G.1150 Ligand excluded by PLIP NAG.25: 2 residues within 4Å: Chain A: N.736, L.941 Ligand excluded by PLIP NAG.26: 3 residues within 4Å: Chain A: A.725, E.1091, N.1093 Ligand excluded by PLIP NAG.27: 2 residues within 4Å: Chain A: N.183, N.184 Ligand excluded by PLIP NAG.28: 2 residues within 4Å: Chain D: F.78, N.80 Ligand excluded by PLIP NAG.29: 3 residues within 4Å: Chain D: N.141, A.142, T.143 Ligand excluded by PLIP NAG.30: 4 residues within 4Å: Chain D: G.218, G.251, I.252, N.253 Ligand excluded by PLIP NAG.31: 2 residues within 4Å: Chain D: N.299, N.301 Ligand excluded by PLIP NAG.32: 2 residues within 4Å: Chain D: N.350, Q.599 Ligand excluded by PLIP NAG.33: 1 residues within 4Å: Chain D: N.622 Ligand excluded by PLIP NAG.34: 1 residues within 4Å: Chain D: N.635 Ligand excluded by PLIP NAG.35: 3 residues within 4Å: Chain D: H.674, V.675, N.676 Ligand excluded by PLIP NAG.36: 2 residues within 4Å: Chain D: N.728, G.1150 Ligand excluded by PLIP NAG.37: 2 residues within 4Å: Chain D: N.736, L.941 Ligand excluded by PLIP NAG.38: 3 residues within 4Å: Chain D: A.725, E.1091, N.1093 Ligand excluded by PLIP NAG.39: 2 residues within 4Å: Chain D: N.183, N.184 Ligand excluded by PLIP NAG.40: 2 residues within 4Å: Chain G: F.78, N.80 Ligand excluded by PLIP NAG.41: 3 residues within 4Å: Chain G: N.141, A.142, T.143 Ligand excluded by PLIP NAG.42: 4 residues within 4Å: Chain G: G.218, G.251, I.252, N.253 Ligand excluded by PLIP NAG.43: 2 residues within 4Å: Chain G: N.299, N.301 Ligand excluded by PLIP NAG.44: 2 residues within 4Å: Chain G: N.350, Q.599 Ligand excluded by PLIP NAG.45: 1 residues within 4Å: Chain G: N.622 Ligand excluded by PLIP NAG.46: 1 residues within 4Å: Chain G: N.635 Ligand excluded by PLIP NAG.47: 3 residues within 4Å: Chain G: H.674, V.675, N.676 Ligand excluded by PLIP NAG.48: 2 residues within 4Å: Chain G: N.728, G.1150 Ligand excluded by PLIP NAG.49: 2 residues within 4Å: Chain G: N.736, L.941 Ligand excluded by PLIP NAG.50: 3 residues within 4Å: Chain G: A.725, E.1091, N.1093 Ligand excluded by PLIP NAG.51: 2 residues within 4Å: Chain G: N.183, N.184 Ligand excluded by PLIP

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Piccoli, L. et al., Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution Serology. Cell (2020)

Release Date

2020-10-14

Peptides

Spike glycoprotein: ADG
S304 Fab light chain: BEH
S304 Fab heavy chain: CFI

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

D
B

G
E

B
L

E
C

H
F

C
H

F
D

I
G

Spike glycoprotein

S304 Fab light chain

S304 Fab heavy chain

Related Entries With Identical Sequence